Concepts (198)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intercellular Signaling Peptides and Proteins | 13 | 2017 | 100 | 3.100 |
Why?
|
| HIV-1 | 18 | 2024 | 747 | 3.080 |
Why?
|
| Virus Replication | 9 | 2024 | 318 | 2.240 |
Why?
|
| Virus Integration | 12 | 2017 | 65 | 1.960 |
Why?
|
| HIV Integrase | 11 | 2017 | 22 | 1.620 |
Why?
|
| Chromatin | 11 | 2017 | 179 | 1.360 |
Why?
|
| Cell Line | 21 | 2019 | 1416 | 1.030 |
Why?
|
| Transcription Factors | 6 | 2016 | 722 | 0.910 |
Why?
|
| Adaptor Proteins, Signal Transducing | 5 | 2016 | 206 | 0.850 |
Why?
|
| Fullerenes | 3 | 2021 | 31 | 0.800 |
Why?
|
| Sequence Deletion | 3 | 2017 | 92 | 0.680 |
Why?
|
| Host-Pathogen Interactions | 2 | 2019 | 203 | 0.670 |
Why?
|
| Viral Proteins | 4 | 2025 | 196 | 0.630 |
Why?
|
| DNA, Viral | 3 | 2017 | 323 | 0.630 |
Why?
|
| Flavivirus Infections | 1 | 2019 | 5 | 0.620 |
Why?
|
| Retroviridae | 2 | 2012 | 25 | 0.620 |
Why?
|
| Avian leukosis virus | 3 | 2016 | 7 | 0.610 |
Why?
|
| Flavivirus | 1 | 2019 | 16 | 0.610 |
Why?
|
| Anti-HIV Agents | 3 | 2021 | 475 | 0.590 |
Why?
|
| DNA, Complementary | 2 | 2017 | 195 | 0.580 |
Why?
|
| Nuclear Proteins | 2 | 2019 | 330 | 0.540 |
Why?
|
| Viruses | 1 | 2017 | 39 | 0.540 |
Why?
|
| Small Molecule Libraries | 1 | 2017 | 60 | 0.530 |
Why?
|
| High Mobility Group Proteins | 1 | 2016 | 4 | 0.510 |
Why?
|
| Transcriptional Elongation Factors | 1 | 2016 | 7 | 0.500 |
Why?
|
| Antiviral Agents | 2 | 2017 | 189 | 0.500 |
Why?
|
| Heterochromatin | 1 | 2016 | 19 | 0.500 |
Why?
|
| HIV Integrase Inhibitors | 1 | 2016 | 10 | 0.490 |
Why?
|
| RNA Interference | 6 | 2009 | 246 | 0.480 |
Why?
|
| DNA-Binding Proteins | 4 | 2016 | 557 | 0.450 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2017 | 276 | 0.450 |
Why?
|
| Gene Knockdown Techniques | 2 | 2019 | 188 | 0.430 |
Why?
|
| Drosophila Proteins | 1 | 2016 | 183 | 0.430 |
Why?
|
| HIV | 3 | 2009 | 100 | 0.410 |
Why?
|
| Virion | 4 | 2021 | 73 | 0.390 |
Why?
|
| Protein Binding | 8 | 2025 | 1076 | 0.380 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2012 | 78 | 0.380 |
Why?
|
| Transcription, Genetic | 2 | 2012 | 599 | 0.380 |
Why?
|
| Humans | 30 | 2025 | 42163 | 0.370 |
Why?
|
| Lentivirus | 3 | 2008 | 24 | 0.350 |
Why?
|
| Gene Expression Regulation, Viral | 3 | 2024 | 115 | 0.350 |
Why?
|
| Protein Interaction Mapping | 1 | 2011 | 64 | 0.340 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2010 | 12 | 0.330 |
Why?
|
| SUMO-1 Protein | 1 | 2010 | 16 | 0.330 |
Why?
|
| Ubiquitins | 1 | 2010 | 47 | 0.330 |
Why?
|
| Promoter Regions, Genetic | 2 | 2010 | 534 | 0.310 |
Why?
|
| Serine | 1 | 2009 | 81 | 0.310 |
Why?
|
| Transcriptional Activation | 1 | 2010 | 173 | 0.310 |
Why?
|
| Antigens, Viral | 3 | 2025 | 50 | 0.300 |
Why?
|
| Histocompatibility Antigens Class I | 2 | 2025 | 32 | 0.280 |
Why?
|
| Integrases | 2 | 2004 | 29 | 0.280 |
Why?
|
| Antigen Presentation | 2 | 2025 | 59 | 0.270 |
Why?
|
| HIV Protease Inhibitors | 2 | 2016 | 24 | 0.260 |
Why?
|
| Cells, Cultured | 5 | 2017 | 1617 | 0.240 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2009 | 115 | 0.230 |
Why?
|
| Codon | 2 | 2024 | 40 | 0.230 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2019 | 189 | 0.230 |
Why?
|
| Cytomegalovirus Infections | 1 | 2025 | 28 | 0.230 |
Why?
|
| Cytomegalovirus | 1 | 2025 | 49 | 0.230 |
Why?
|
| Oncogenic Viruses | 1 | 2004 | 2 | 0.220 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2025 | 181 | 0.210 |
Why?
|
| Chickens | 2 | 2016 | 148 | 0.200 |
Why?
|
| RNA, Messenger | 3 | 2024 | 1265 | 0.200 |
Why?
|
| Protein Biosynthesis | 1 | 2024 | 136 | 0.200 |
Why?
|
| Caveolins | 1 | 2002 | 9 | 0.190 |
Why?
|
| Genome, Viral | 2 | 2021 | 118 | 0.190 |
Why?
|
| Nucleocapsid Proteins | 1 | 2021 | 12 | 0.180 |
Why?
|
| Cell Survival | 3 | 2016 | 934 | 0.180 |
Why?
|
| Nuclear Localization Signals | 3 | 2006 | 14 | 0.180 |
Why?
|
| gag Gene Products, Human Immunodeficiency Virus | 2 | 2021 | 18 | 0.170 |
Why?
|
| Gene Expression | 2 | 2019 | 692 | 0.170 |
Why?
|
| RNA, Viral | 1 | 2021 | 317 | 0.160 |
Why?
|
| Interferon Type I | 1 | 2019 | 18 | 0.160 |
Why?
|
| RNA Viruses | 1 | 2019 | 22 | 0.160 |
Why?
|
| RNA, Transfer | 1 | 2019 | 29 | 0.150 |
Why?
|
| Mason-Pfizer monkey virus | 1 | 2018 | 1 | 0.150 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2009 | 293 | 0.140 |
Why?
|
| Virus Assembly | 1 | 2018 | 44 | 0.140 |
Why?
|
| Terminal Repeat Sequences | 1 | 2017 | 8 | 0.140 |
Why?
|
| Cysteine | 1 | 2018 | 101 | 0.140 |
Why?
|
| Capsid Proteins | 1 | 2018 | 74 | 0.140 |
Why?
|
| Histone Chaperones | 1 | 2017 | 1 | 0.140 |
Why?
|
| Kinetics | 1 | 2019 | 698 | 0.140 |
Why?
|
| Animals | 9 | 2016 | 16695 | 0.140 |
Why?
|
| Transfection | 4 | 2014 | 526 | 0.130 |
Why?
|
| HIV Core Protein p24 | 1 | 2016 | 11 | 0.130 |
Why?
|
| Cell Line, Tumor | 1 | 2024 | 2598 | 0.130 |
Why?
|
| Histones | 2 | 2016 | 194 | 0.130 |
Why?
|
| Pyrrolidines | 1 | 2016 | 30 | 0.130 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2010 | 184 | 0.120 |
Why?
|
| Drug Resistance, Viral | 1 | 2016 | 67 | 0.120 |
Why?
|
| Gene Deletion | 2 | 2009 | 168 | 0.120 |
Why?
|
| HIV Infections | 3 | 2024 | 2535 | 0.120 |
Why?
|
| Histone Deacetylases | 1 | 2016 | 61 | 0.120 |
Why?
|
| DNA Replication | 1 | 2016 | 153 | 0.120 |
Why?
|
| Drosophila | 1 | 2016 | 150 | 0.110 |
Why?
|
| Gene Products, rev | 2 | 2004 | 4 | 0.110 |
Why?
|
| Genetic Vectors | 2 | 2018 | 165 | 0.110 |
Why?
|
| Leukemia Virus, Murine | 1 | 2012 | 3 | 0.100 |
Why?
|
| Vesicular stomatitis Indiana virus | 1 | 2012 | 7 | 0.100 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2014 | 165 | 0.100 |
Why?
|
| Jurkat Cells | 1 | 2012 | 84 | 0.100 |
Why?
|
| Gene Knockout Techniques | 1 | 2012 | 54 | 0.100 |
Why?
|
| DNA | 2 | 2005 | 594 | 0.090 |
Why?
|
| Molecular Sequence Data | 3 | 2009 | 1559 | 0.090 |
Why?
|
| Mutation | 3 | 2018 | 1169 | 0.090 |
Why?
|
| Protein Structure, Tertiary | 3 | 2009 | 427 | 0.090 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2011 | 41 | 0.090 |
Why?
|
| Mutant Proteins | 1 | 2011 | 52 | 0.090 |
Why?
|
| Proviruses | 2 | 2018 | 35 | 0.080 |
Why?
|
| Half-Life | 1 | 2010 | 63 | 0.080 |
Why?
|
| Immunoblotting | 2 | 2014 | 181 | 0.080 |
Why?
|
| Amino Acid Substitution | 1 | 2010 | 135 | 0.080 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2014 | 350 | 0.080 |
Why?
|
| Papillomavirus Infections | 1 | 2014 | 363 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2014 | 649 | 0.070 |
Why?
|
| Amino Acid Sequence | 2 | 2009 | 1188 | 0.070 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily D | 2 | 2025 | 2 | 0.070 |
Why?
|
| Infectious Anemia Virus, Equine | 1 | 2007 | 1 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2014 | 933 | 0.070 |
Why?
|
| rev Gene Products, Human Immunodeficiency Virus | 2 | 2004 | 3 | 0.070 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2005 | 60 | 0.070 |
Why?
|
| Virulence | 1 | 2007 | 238 | 0.070 |
Why?
|
| Mice | 5 | 2009 | 6490 | 0.060 |
Why?
|
| T-Lymphocytes | 1 | 2009 | 378 | 0.060 |
Why?
|
| Chromosomes, Human | 1 | 2006 | 37 | 0.060 |
Why?
|
| Blotting, Western | 2 | 2005 | 884 | 0.060 |
Why?
|
| Protein Structure, Secondary | 1 | 2006 | 185 | 0.060 |
Why?
|
| Amino Acids | 1 | 2006 | 150 | 0.060 |
Why?
|
| Viral Matrix Proteins | 1 | 2025 | 18 | 0.060 |
Why?
|
| Peptide Fragments | 2 | 2009 | 301 | 0.060 |
Why?
|
| Immunodeficiency Virus, Feline | 1 | 2004 | 2 | 0.060 |
Why?
|
| Interleukin-2 | 1 | 2025 | 90 | 0.060 |
Why?
|
| Macrophages | 1 | 2009 | 515 | 0.060 |
Why?
|
| Protease Inhibitors | 1 | 2004 | 53 | 0.050 |
Why?
|
| Immunoprecipitation | 1 | 2004 | 128 | 0.050 |
Why?
|
| Introns | 1 | 2004 | 80 | 0.050 |
Why?
|
| Genes, vpu | 1 | 2004 | 1 | 0.050 |
Why?
|
| Genes, vif | 1 | 2004 | 1 | 0.050 |
Why?
|
| Cytoplasm | 1 | 2004 | 154 | 0.050 |
Why?
|
| Ubiquitin | 1 | 2004 | 80 | 0.050 |
Why?
|
| Microscopy, Confocal | 1 | 2004 | 223 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 1 | 2004 | 254 | 0.050 |
Why?
|
| Plasmids | 1 | 2004 | 247 | 0.050 |
Why?
|
| Phosphoproteins | 1 | 2025 | 201 | 0.050 |
Why?
|
| Respirovirus | 1 | 2002 | 3 | 0.050 |
Why?
|
| HIV-2 | 1 | 2002 | 9 | 0.050 |
Why?
|
| Defective Viruses | 1 | 2002 | 10 | 0.050 |
Why?
|
| Cell Nucleus | 1 | 2004 | 383 | 0.050 |
Why?
|
| Caveolin 1 | 1 | 2002 | 33 | 0.050 |
Why?
|
| Protein Sorting Signals | 1 | 2002 | 26 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2002 | 196 | 0.050 |
Why?
|
| Herpesvirus 4, Human | 1 | 2002 | 36 | 0.050 |
Why?
|
| HLA Antigens | 1 | 2002 | 27 | 0.050 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2002 | 26 | 0.050 |
Why?
|
| Lectins, C-Type | 1 | 2002 | 37 | 0.050 |
Why?
|
| Peptides | 1 | 2025 | 357 | 0.050 |
Why?
|
| Reverse Transcription | 1 | 2021 | 23 | 0.050 |
Why?
|
| Trans-Activators | 1 | 2002 | 190 | 0.040 |
Why?
|
| Nucleosomes | 1 | 2017 | 31 | 0.030 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2017 | 44 | 0.030 |
Why?
|
| Base Sequence | 2 | 2009 | 997 | 0.030 |
Why?
|
| HIV Protease | 1 | 2016 | 22 | 0.030 |
Why?
|
| Cations | 1 | 2016 | 49 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2016 | 232 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2016 | 491 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2016 | 560 | 0.030 |
Why?
|
| Papillomavirus E7 Proteins | 1 | 2014 | 16 | 0.030 |
Why?
|
| Oncogene Proteins, Viral | 1 | 2014 | 25 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 1112 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 436 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2014 | 928 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2014 | 267 | 0.020 |
Why?
|
| Intracellular Fluid | 1 | 2008 | 27 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2009 | 207 | 0.020 |
Why?
|
| Consensus Sequence | 1 | 2007 | 20 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2008 | 151 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2005 | 64 | 0.010 |
Why?
|
| Genes, Regulator | 1 | 2005 | 27 | 0.010 |
Why?
|
| NIH 3T3 Cells | 1 | 2005 | 64 | 0.010 |
Why?
|
| Cats | 1 | 2005 | 80 | 0.010 |
Why?
|
| Gene Silencing | 1 | 2005 | 154 | 0.010 |
Why?
|
| Vero Cells | 1 | 2005 | 109 | 0.010 |
Why?
|
| Protein Transport | 1 | 2005 | 295 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2005 | 348 | 0.010 |
Why?
|
| HLA-C Antigens | 1 | 2002 | 5 | 0.010 |
Why?
|
| beta 2-Microglobulin | 1 | 2002 | 10 | 0.010 |
Why?
|
| HLA-A Antigens | 1 | 2002 | 7 | 0.010 |
Why?
|
| HLA-B Antigens | 1 | 2002 | 11 | 0.010 |
Why?
|
| Clone Cells | 1 | 2002 | 50 | 0.010 |
Why?
|
| Biopolymers | 1 | 2002 | 17 | 0.010 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2002 | 31 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2002 | 122 | 0.010 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2002 | 83 | 0.010 |
Why?
|
| Killer Cells, Natural | 1 | 2002 | 99 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2002 | 221 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2002 | 301 | 0.010 |
Why?
|
| Female | 1 | 2014 | 24018 | 0.010 |
Why?
|